Medtronic has initiated the commercial introduction in the United States of the ACD Instrument Set, a brand new set of instruments that can be used to insert the clinically proven Bryan Cervical Disc. The launch announcement was made at the Congress of Neurological Surgeons Annual Meeting (Chicago, USA, 6–10 October).
The Bryan Disc was FDA approved in 2009 for the treatment of single-level cervical disc disease (radiculopathy and/or myelopathy), one of the most common diagnoses for neck and arm pain. The Bryan Disc is one of two clinically proven artificial cervical discs in the Medtronic portfolio.
“The new ACD Instrument Set allows surgeons to implant the clinically proven Bryan Disc using the same basic surgical steps taught in anterior cervical surgery for over 50 years with excellent success rates,” said Rick Sasso, Indiana Spine Group. “The original instrument set for the Bryan Disc requires specialised instruments that must be assembled and mounted to the operating room table during surgery, a much different technique than I learned in my fellowship training,” added Sasso.
“We are the only company with two clinically proven artificial cervical discs in its portfolio, both with different designs and made of different materials, in order to accommodate surgeon preference,” said Doug King, senior vice president and president of Medtronic’s Spinal business. “We are very excited to provide this enhanced instrument set and motion device to physicians seeking to offer their patients an alternative to fusion,” said King.
The Bryan Cervical Disc System incorporates technology developed by Gary K Michelson.
